Cargando…

Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)

PURPOSE: In men with localized prostate cancer, dose-escalated conformal radiotherapy (CFRT) improves efficacy outcomes at the cost of increased toxicity. We present a detailed analysis to provide further information about the incidence and prevalence of late gastrointestinal side effects. METHODS A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Syndikus, Isabel, Morgan, Rachel C., Sydes, Matthew R., Graham, John D., Dearnaley, David P.
Formato:	Texto
Lenguaje:	English
Publicado:	Elsevier Science Inc 2010
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937212/ https://www.ncbi.nlm.nih.gov/pubmed/19836155 http://dx.doi.org/10.1016/j.ijrobp.2009.05.052

Ejemplares similares

Accuracy and Reproducibility of Conformal Radiotherapy using Data from a Randomised Controlled Trial of Conformal Radiotherapy in Prostate Cancer (MRC RT01, ISRCTN47772397)
por: Stanley, S., et al.
Publicado: (2008)

Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397)
por: Lemanska, Agnieszka, et al.
Publicado: (2017)

Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial
por: Kass-Iliyya, Antoine, et al.
Publicado: (2018)

Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up
por: Creak, A, et al.
Publicado: (2013)

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
por: Dearnaley, D P, et al.
Publicado: (2005)

Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer
por: Lemanska, A., et al.
Publicado: (2018)

Access Status of Council Documents as from 01.04.2009
Publicado: (2009)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

Superiority of helical tomotherapy on liver sparing and dose escalation in hepatocellular carcinoma: a comparison study of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy
por: Zhao, Qianqian, et al.
Publicado: (2016)

Hewitt launches Research Councils UK
Publicado: (2002)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer
por: Lee, Kyong Joo, et al.
Publicado: (2016)

UK physicists welcome research council reforms
Publicado: (2010)

A randomised trial of an internet weight control resource: The UK Weight Control Trial [ISRCTN58621669]
por: Kirk, Sara FL, et al.
Publicado: (2003)

A review of sample sizes for UK pilot and feasibility studies on the ISRCTN registry from 2013 to 2020
por: Totton, Nikki, et al.
Publicado: (2023)

Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer
por: Jo, Sunmi, et al.
Publicado: (2016)

Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449]
por: Hemmelgarn, Brenda R, et al.
Publicado: (2006)

Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
por: Kim, Jun Won, et al.
Publicado: (2017)

UK Government: eminent scientists appointed to the Research Councils
Publicado: (2003)

The Resuscitation Council UK Immediate Life Support Course
por: Perkins, GD, et al.
Publicado: (2003)

CRASH2 in Germany [ISRCTN86750102]
por: Chung, CH, et al.
Publicado: (2006)

Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma
por: Sanguineti, G, et al.
Publicado: (2002)

Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
por: Cihoric, Nikola, et al.
Publicado: (2015)

Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer
por: Kim, Hyung Jin, et al.
Publicado: (2016)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Conformational Targeting of Fibrillar Polyglutamine Proteins in Live Cells Escalates Aggregation and Cytotoxicity
por: Kvam, Erik, et al.
Publicado: (2009)

Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition
por: Brand, Douglas H., et al.
Publicado: (2023)

Efforts escalate to protect homeless people from COVID-19 in UK
por: Kirby, Tony
Publicado: (2020)

Publisher Correction: Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
por: Kim, Jun Won, et al.
Publicado: (2018)

Fundraising – Grant offered by the UK Science and Technology Facilities Council
Publicado: (2018)

Fundraising – Grant offered by the UK Science and Technology Facilities Council
Publicado: (2017)

The UK Medical Research Council and clinical trials, 1934-1960
por: Chalmers, Iain
Publicado: (2013)

Image guided dose escalated prostate radiotherapy: still room to improve
por: Martin, Jarad M, et al.
Publicado: (2009)

Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer
por: Rosenbrock, Johannes, et al.
Publicado: (2023)

Is radiotherapy after primary chemotherapy (RAPCHEM) on the right path to de-escalation?
por: Socha, Joanna, et al.
Publicado: (2023)

The ISRCTN Register: achievements and challenges 8 years on
por: Faure, Helene, et al.
Publicado: (2011)

Randomised controlled trial of the effects of physical activity feedback on awareness and behaviour in UK adults: the FAB study protocol [ISRCTN92551397]
por: Watkinson, Clare, et al.
Publicado: (2010)

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity
por: Naismith, O.F., et al.
Publicado: (2019)

Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer
por: Peach, Matthew Sean, et al.
Publicado: (2015)

P09.17 Changes in the Management of Patients Having Radical Radiotherapy in the UK During the COVID-19 Pandemic (COVID-RT Lung)
por: Banfill, K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4djuemoi41isv7ufpeqsij1r6d